CALHM2 and Alzheimer disease: In particular, in 5×FAD mice carrying five familial AD gene mutations, both conventional knockout of Calhm2 and conditional microglial knockout of Calhm2 significantly reduce Aβ deposition, neuroinflammation, and cognitive impairments.